THC vs HCA

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 10, 2026

THC

37.8
AI Score
VS
THC Wins

HCA

37.0
AI Score

Investment Advisor Scores

THC

38score
Recommendation
SELL

HCA

37score
Recommendation
SELL

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric THC HCA Winner
Revenue 59.19B 16.63B HCA
Net Income 4.90B 3.17B HCA
Net Margin 8.3% 19.1% THC
ROE -60.6% 58.2% THC
ROA 7.7% 10.0% THC
Total Assets 63.45B 31.59B HCA
Cash 908.00M 2.67B THC
Current Ratio 0.82 1.58 THC
Free Cash Flow 5.10B 2.96B HCA

Relative Price Performance (Last 90 Days)

THC 1M: +8.0% · 3M: +8.8% HCA 1M: +10.0% · 3M: +21.7%

Current Technical Phase

THC

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (1.1% over 20 days), RSI 64

RSI (14): 64.1 · Price: $290.27

HCA

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (5.7% over 20 days), RSI 65

RSI (14): 64.7 · Price: $504.42

Fundamentals Snapshot

Metric THC HCA
Market Cap — —
Forward P/E 14.3 16.1
Trailing P/E 8.4 16.4
Revenue (TTM) — —
Revenue Growth 0.1% 0.0%
Gross Margin 0.4% 0.4%
Operating Margin 0.2% 0.1%
EPS 34.29 30.75
Dividend Yield — 0.01%

Frequently Asked Questions

Based on our detailed analysis, THC is currently the stronger investment candidate, winning 5 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.